| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.
|
Pediatrics
|
2006
|
2.55
|
|
2
|
A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia.
|
Vaccine
|
2002
|
1.68
|
|
3
|
Australia's contribution to global immunisation.
|
Aust N Z J Public Health
|
2012
|
1.39
|
|
4
|
Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination.
|
Pediatr Infect Dis J
|
2015
|
1.38
|
|
5
|
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine.
|
J Infect Dis
|
2007
|
1.20
|
|
6
|
Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.
|
Pediatrics
|
2011
|
1.07
|
|
7
|
Improving influenza vaccination coverage in pregnancy in Melbourne 2010-2011.
|
Aust N Z J Obstet Gynaecol
|
2012
|
1.07
|
|
8
|
Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception.
|
BMC Public Health
|
2011
|
1.00
|
|
9
|
The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use.
|
Commun Dis Intell Q Rep
|
2004
|
0.99
|
|
10
|
Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults.
|
BMC Infect Dis
|
2012
|
0.93
|
|
11
|
Virus detection and its association with symptoms during influenza-like illness in a sample of healthy adults enrolled in a randomised controlled vaccine trial.
|
Influenza Other Respir Viruses
|
2012
|
0.90
|
|
12
|
Cognitive and executive function 12 years after childhood bacterial meningitis: effect of acute neurologic complications and age of onset.
|
J Pediatr Psychol
|
2004
|
0.90
|
|
13
|
Optimal dosing and dynamic distribution of vaccines in an influenza pandemic.
|
Am J Epidemiol
|
2009
|
0.84
|
|
14
|
Influence of contact definitions in assessment of the relative importance of social settings in disease transmission risk.
|
PLoS One
|
2012
|
0.84
|
|
15
|
Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
|
Influenza Other Respir Viruses
|
2010
|
0.82
|
|
16
|
Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
|
Influenza Other Respir Viruses
|
2013
|
0.82
|
|
17
|
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
|
Vaccine
|
2010
|
0.81
|
|
18
|
Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers.
|
Pediatr Infect Dis J
|
2013
|
0.79
|
|
19
|
A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
|
Pediatr Infect Dis J
|
2012
|
0.78
|
|
20
|
Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age.
|
Pediatr Infect Dis J
|
2011
|
0.78
|
|
21
|
Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis.
|
J Pediatr
|
2004
|
0.77
|
|
22
|
Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed Toddlers.
|
Pediatr Infect Dis J
|
2015
|
0.77
|
|
23
|
Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials.
|
Hum Vaccin Immunother
|
2012
|
0.77
|
|
24
|
The safety profile of Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY).
|
Hum Vaccin Immunother
|
2012
|
0.77
|
|
25
|
Increases in vaccination coverage for children in child care, 1997 to 2000: an evaluation of the impact of government incentives and initiatives.
|
Aust N Z J Public Health
|
2002
|
0.76
|
|
26
|
A positive approach to parents with concerns about vaccination for the family physician.
|
Aust Fam Physician
|
2014
|
0.76
|
|
27
|
Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009.
|
Expert Rev Vaccines
|
2011
|
0.76
|
|
28
|
Detection of a divergent Parainfluenza 4 virus in an adult patient with influenza like illness using next-generation sequencing.
|
BMC Infect Dis
|
2014
|
0.76
|
|
29
|
Child influenza vaccination. Panvax febrile reactions not a predictor.
|
BMJ
|
2010
|
0.75
|
|
30
|
Climate transformation: the next revolution in public health?
|
J Public Health (Oxf)
|
2008
|
0.75
|
|
31
|
Upward bound. Interview by Lindsey Wahowiak.
|
Diabetes Forecast
|
2013
|
0.75
|
|
32
|
Electroencephalographic abnormalities during sleep in children with developmental speech-language disorders: a case-control study.
|
Dev Med Child Neurol
|
2009
|
0.75
|